CVS HEALTH CORPORATION (CVS) Free cash flow
- Free cash flow · 12 months (USD): Value $11.76B; Formula and calculation Operating cash flow minus capital spending; distinct from the saved levered FCF quote figure. Period ending 2026-06-30..
- Price / free cash flow · 12 months: Value (m); Formula and calculation Market cap / trailing-year free cash flow; inverse of FCF yield before percent scaling. Period ending 2026-06-30..
- Free cash flow yield · 12 months: Value (m); Formula and calculation (Operating cash flow − capital spending) / current market cap. Period ending 2026-06-30..
- Free cash flow margin · 12 months: Value 2.83%; Formula and calculation (Operating cash flow − capital spending) / revenue. Period ending 2026-06-30..
Free cash flow
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Free cash flow · 12 months (USD) | $11.76B | Operating cash flow minus capital spending; distinct from the saved levered FCF quote figure. Period ending 2026-06-30. $14.78B − $3.02B ≈ $11.76B |
| Price / free cash flow · 12 months | (m) | Market cap / trailing-year free cash flow; inverse of FCF yield before percent scaling. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
| Free cash flow yield · 12 months | (m) | (Operating cash flow − capital spending) / current market cap. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
| Free cash flow margin · 12 months | 2.83% | (Operating cash flow − capital spending) / revenue. Period ending 2026-06-30. $11.76B ÷ $415.09B × 100 ≈ 2.83% |
| Free cash flow per share · 12 months | (m) | (Trailing-year operating cash flow − capital spending) / reported quarter-end common shares. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
| Operating cash flow · 12 months | $14.78B | Cash generated by operating activities. Period ending 2026-06-30. |
| Operating cash flow / net income · 12 months | 3.02× | Operating cash flow / net income. Period ending 2026-06-30. $14.78B ÷ $4.89B ≈ 3.02× |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Operating cash flow | 14.78B USD | Net Cash Provided by (Used in) Operating Activities |
| Capital spending | 3.02B USD | Payments to Acquire Property, Plant, and Equipment |
| Market cap | (m) | |
| Free cash flow | 11.76B USD | Net Cash Provided by (Used in) Operating Activities · Payments to Acquire Property, Plant, and Equipment |
| Revenue | 415.09B USD | Revenue from Contract with Customer, Excluding Assessed Tax |
| Quarter-end shares | (m) | Common Stock, Shares, Outstanding |
| Net income | 4.89B USD | Net Income (Loss) Attributable to Parent |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Free cash flow | FCF per share | Operating cash flow | Capital spending (USD) | Market cap (USD) | Revenue (USD) | Quarter-end shares (shares) | Net income (USD) | Price / FCF | FCF yield | FCF margin | Cash conversion |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $11.76B | (m) | $14.78B | $3.02B | (m) | $415.09B | (m) | $4.89B | (m) | (m) | 2.83% | 3.02× |
| 2026-03-31 | $7.39B | (m) | $10.33B | $2.94B | (m) | $407.90B | (m) | $2.93B | (m) | (m) | 1.81% | 3.52× |
| 2025-12-31 | $7.81B | (m) | $10.64B | $2.83B | (m) | $402.07B | (m) | $1.77B | (m) | (m) | 1.94% | 6.02× |
| 2025-09-30 | $6.29B | (m) | $9.11B | $2.82B | (m) | $394.08B | (m) | $469.00M | (m) | (m) | 1.60% | 19.42× |
| 2025-06-30 | $4.78B | (m) | $7.57B | $2.79B | (m) | $386.64B | (m) | $4.53B | (m) | (m) | 1.24% | 1.67× |
| 2025-03-31 | $5.94B | (m) | $8.76B | $2.82B | (m) | $378.96B | (m) | $5.28B | (m) | (m) | 1.57% | 1.66× |
| 2024-12-31 | $6.33B | (m) | $9.11B | $2.78B | (m) | $372.81B | (m) | $4.61B | (m) | (m) | 1.70% | 1.97× |
| 2024-09-30 | $1.69B | (m) | $4.61B | $2.92B | (m) | $368.91B | (m) | $5.02B | (m) | (m) | 0.46% | 0.92× |
| 2024-06-30 | $5.27B | (m) | $8.07B | $2.80B | (m) | $363.25B | (m) | $7.19B | (m) | (m) | 1.45% | 1.12× |
| 2024-03-31 | $8.14B | (m) | $10.89B | $2.75B | (m) | $360.94B | (m) | $7.32B | (m) | (m) | 2.25% | 1.49× |
| 2023-12-31 | $10.39B | (m) | $13.43B | $3.03B | (m) | $357.78B | (m) | $8.34B | (m) | (m) | 2.91% | 1.61× |
| 2023-09-30 | $11.30B | (m) | $14.11B | $2.81B | (m) | $347.81B | (m) | $8.63B | (m) | (m) | 3.25% | 1.63× |
| 2023-06-30 | $17.67B | (m) | $20.52B | $2.84B | (m) | $339.20B | (m) | $2.96B | (m) | (m) | 5.21% | 6.92× |
| 2023-03-31 | $17.39B | (m) | $20.05B | $2.66B | (m) | $330.92B | (m) | $3.93B | (m) | (m) | 5.26% | 5.10× |
| 2022-12-31 | $13.45B | (m) | $16.18B | $2.73B | (m) | $322.47B | (m) | $4.15B | (m) | (m) | 4.17% | 3.90× |
| 2022-09-30 | $19.50B | (m) | $22.13B | $2.64B | (m) | $315.23B | (m) | $3.15B | (m) | (m) | 6.19% | 7.02× |
| 2022-06-30 | $15.87B | (m) | $18.53B | $2.66B | (m) | $307.86B | (m) | $8.17B | (m) | (m) | 5.15% | 2.27× |
| 2022-03-31 | $16.19B | (m) | $18.94B | $2.74B | (m) | $299.84B | (m) | $8.00B | (m) | (m) | 5.40% | 2.37× |
| 2021-12-31 | $15.74B | (m) | $18.27B | $2.52B | (m) | $292.11B | (m) | $7.91B | (m) | (m) | 5.39% | 2.31× |
| 2021-09-30 | $15.19B | (m) | $17.83B | $2.64B | (m) | $285.06B | (m) | $7.58B | (m) | (m) | 5.33% | 2.35× |
| 2021-06-30 | $11.62B | (m) | $14.18B | $2.56B | (m) | $278.32B | (m) | $7.20B | (m) | (m) | 4.17% | 1.97× |
| 2021-03-31 | $12.93B | (m) | $15.45B | $2.52B | (m) | $271.05B | (m) | $7.39B | (m) | (m) | 4.77% | 2.09× |
| 2020-12-31 | $13.43B | (m) | $15.87B | $2.44B | (m) | $268.71B | (m) | $7.18B | (m) | (m) | 5.00% | 2.21× |
| 2020-09-30 | $12.64B | (m) | $14.93B | $2.29B | (m) | $266.85B | (m) | $7.95B | (m) | (m) | 4.74% | 1.88× |
| 2020-06-30 | $13.63B | (m) | $15.99B | $2.36B | (m) | $264.34B | (m) | $8.26B | (m) | (m) | 5.16% | 1.94× |
| 2020-03-31 | $11.72B | (m) | $14.21B | $2.48B | (m) | $262.13B | (m) | $7.22B | (m) | (m) | 4.47% | 1.97× |
| 2019-12-31 | $10.39B | (m) | $12.85B | $2.46B | (m) | $256.78B | (m) | $6.63B | (m) | (m) | 4.05% | 1.94× |
| 2019-09-30 | $10.22B | (m) | $12.69B | $2.48B | (m) | $243.33B | (m) | $4.47B | (m) | (m) | 4.20% | 2.84× |
| 2019-06-30 | $8.45B | (m) | $10.86B | $2.41B | (m) | $226.05B | (m) | $4.33B | (m) | (m) | 3.74% | 2.51× |
| 2019-03-31 | $6.19B | (m) | $8.46B | $2.27B | (m) | $209.62B | (m) | (m) | (m) | (m) | 2.95% | (m) |
| 2018-12-31 | $6.83B | (m) | $8.87B | $2.04B | (m) | $193.92B | (m) | $-594.00M | (m) | (m) | 3.52% | -14.92× |
| 2018-09-30 | $4.29B | (m) | $6.25B | $1.96B | (m) | $188.06B | (m) | $3.11B | (m) | (m) | 2.28% | 2.01× |
| 2018-06-30 | $5.82B | (m) | $7.76B | $1.94B | (m) | $186.97B | (m) | $3.01B | (m) | (m) | 3.11% | 2.58× |
| 2018-03-31 | $4.89B | (m) | $6.83B | $1.94B | (m) | $185.94B | (m) | $6.67B | (m) | (m) | 2.63% | 1.02× |
| 2017-12-31 | $6.09B | (m) | $8.01B | $1.92B | (m) | $184.76B | (m) | $6.62B | (m) | (m) | 3.30% | 1.21× |
| 2017-09-30 | $8.16B | (m) | $10.19B | $2.03B | (m) | $182.35B | (m) | $5.04B | (m) | (m) | 4.48% | 2.02× |
| 2017-06-30 | $9.51B | (m) | $11.52B | $2.01B | (m) | $180.78B | (m) | $5.30B | (m) | (m) | 5.26% | 2.17× |
| 2017-03-31 | $9.08B | (m) | $11.16B | $2.08B | (m) | $178.82B | (m) | $5.12B | (m) | (m) | 5.08% | 2.18× |
| 2016-12-31 | $7.84B | (m) | $10.07B | $2.22B | (m) | $177.53B | (m) | $5.32B | (m) | (m) | 4.42% | 1.89× |
| 2016-09-30 | $9.04B | (m) | $11.52B | $2.48B | (m) | $172.70B | (m) | (m) | (m) | (m) | 5.23% | (m) |
| 2016-06-30 | $6.89B | (m) | $9.41B | $2.53B | (m) | $166.73B | (m) | (m) | (m) | (m) | 4.13% | (m) |
| 2016-03-31 | $6.29B | (m) | $8.84B | $2.55B | (m) | $160.17B | (m) | (m) | (m) | (m) | 3.93% | (m) |
| 2015-12-31 | $6.04B | (m) | $8.41B | $2.37B | (m) | $153.29B | (m) | (m) | (m) | (m) | 3.94% | (m) |
| 2015-09-30 | $6.07B | (m) | $8.26B | $2.19B | (m) | $149.20B | (m) | (m) | (m) | (m) | 4.07% | (m) |
| 2015-06-30 | $5.90B | (m) | $8.09B | $2.19B | (m) | $145.58B | (m) | (m) | (m) | (m) | 4.05% | (m) |
| 2015-03-31 | $5.78B | (m) | $7.95B | $2.17B | (m) | $143.01B | (m) | (m) | (m) | (m) | 4.04% | (m) |
| 2014-12-31 | $6.00B | (m) | $8.14B | $2.14B | (m) | $139.37B | (m) | (m) | (m) | (m) | 4.31% | (m) |
| 2014-09-30 | $4.16B | (m) | $6.25B | $2.09B | (m) | $135.14B | (m) | (m) | (m) | (m) | 3.08% | (m) |
| 2014-06-30 | $4.24B | (m) | $6.31B | $2.07B | (m) | $132.05B | (m) | (m) | (m) | (m) | 3.21% | (m) |
| 2014-03-31 | $4.26B | (m) | $6.32B | $2.05B | (m) | $128.70B | (m) | (m) | (m) | (m) | 3.31% | (m) |
| 2013-12-31 | $3.80B | (m) | $5.78B | $1.98B | (m) | $126.76B | (m) | (m) | (m) | (m) | 3.00% | (m) |
| 2013-09-30 | $3.93B | (m) | $5.98B | $2.05B | (m) | $125.37B | (m) | (m) | (m) | (m) | 3.13% | (m) |
| 2013-06-30 | $3.18B | (m) | $5.20B | $2.02B | (m) | $123.63B | (m) | (m) | (m) | (m) | 2.57% | (m) |
| 2013-03-31 | $3.55B | (m) | $5.53B | $1.97B | (m) | $123.10B | (m) | (m) | (m) | (m) | 2.89% | (m) |
| 2012-12-31 | $4.64B | (m) | $6.67B | $2.03B | (m) | $123.13B | (m) | (m) | (m) | (m) | 3.77% | (m) |
| 2012-09-30 | $3.74B | (m) | $5.76B | $2.02B | (m) | $120.06B | (m) | (m) | (m) | (m) | 3.12% | (m) |
| 2012-06-30 | $4.82B | (m) | $6.80B | $1.98B | (m) | $116.50B | (m) | (m) | (m) | (m) | 4.14% | (m) |
| 2012-03-31 | $4.84B | (m) | $6.78B | $1.94B | (m) | $112.20B | (m) | (m) | (m) | (m) | 4.31% | (m) |
| 2011-12-31 | $3.98B | (m) | $5.86B | $1.87B | (m) | $107.10B | (m) | (m) | (m) | (m) | 3.72% | (m) |
| 2011-09-30 | $5.02B | (m) | $6.81B | $1.79B | (m) | $104.01B | (m) | (m) | (m) | (m) | 4.82% | (m) |
| 2011-06-30 | $4.29B | (m) | $6.14B | $1.85B | (m) | $101.16B | (m) | $3.36B | (m) | (m) | 4.24% | 1.83× |
| 2011-03-31 | $3.67B | (m) | $5.58B | $1.91B | (m) | $98.53B | (m) | $3.37B | (m) | (m) | 3.73% | 1.66× |
| 2010-12-31 | $2.77B | (m) | $4.78B | $2.00B | (m) | $96.41B | (m) | $3.43B | (m) | (m) | 2.88% | 1.39× |
| 2010-09-30 | $2.63B | (m) | $4.81B | $2.17B | (m) | $97.46B | (m) | $3.45B | (m) | (m) | 2.70% | 1.39× |
| 2010-06-30 | $2.10B | (m) | $4.42B | $2.32B | (m) | $98.23B | (m) | $3.66B | (m) | (m) | 2.14% | 1.21× |
| 2010-03-31 | $1.84B | (m) | $4.32B | $2.48B | (m) | $99.09B | (m) | $3.73B | (m) | (m) | 1.86% | 1.16× |
| 2009-12-31 | $1.49B | (m) | $4.04B | $2.55B | (m) | $98.73B | (m) | $3.70B | (m) | (m) | 1.51% | 1.09× |
| 2009-09-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2009-06-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2009-03-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2008-12-31 | $1.77B | (m) | $3.95B | $2.18B | (m) | $87.47B | (m) | $3.21B | (m) | (m) | 2.02% | 1.23× |
| 2008-09-27 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2008-06-28 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2007-12-29 | $1.43B | (m) | $3.23B | $1.80B | (m) | $76.33B | (m) | $2.64B | (m) | (m) | 1.87% | 1.22× |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PETMED EXPRESS INC (PETS) | United States | $0.034B | -1.41 |